The nurse would anticipate administering fondaparinux to a client with which condition?

Question

26-10-2022
Health

contestada

The nurse would anticipate administering fondaparinux to a client with which condition?

Respuesta :

Otras preguntas

Existing fire service facilities in areas prone to catastrophic natural disasters can better protect its occupants by the addition of: Group of answer choices a

A circle with a radius of 21 feet is cut into 7 equal pieces. How many square feet are 4 of the pieces? Use 22 over 7 for π.

Provide insight into the National Transportation Security Act of November 2001.

32- What is the IUPAC nomenclature of the opposite compound?a) 3-chloro-2-fluoro-1-hydroxy benzeneb) 5-chloro-6-fluorophenolc) 2-fluoro-6-chlorophenold) 3-chlor

What imagery occurs in Sonnet 130 by William Shakespeare

Find the roots of 2x^3+x^2+13x+6=0

O With renewed determination, I embraced the challenges ahead, ready to make my mark on the corporate landscape.DQuestion 12 Muple Choice Worth 2 points)(05.01

What is the distance from X to the rock? The angle at X and the turn are both 90°. From X to Jon is 19 feet and from Jon to the twSally is 29 feet. Round to the

Which of the following would apply to disrespecting users' autonomy to increase revenue?a. Ensure that the public good is the central concern during all profess

dom, trails there are still for womenFearless to break and tread"Keep watch on power as it passes, on liberty's torch as it[20] travels, lest woman be left with

QWTiffany QWTiffany · Answer 1 · 2022-10-27T17:42:47+02:00

The nurse would anticipate administering fondaparinux to a client with DVT prophylaxis.

Fondaparinux is sold by the company GlaxoSmithKine. It is sold by the trade name Arixtra. The drug aims at treatment of deep vein thrombosis and pulmonary embolism. Deep vein thrombosis is the condition where blood clots form in blood vessels present in legs.

Through the blood flow, these clots can move to lungs and hence may result in pulmonary embolism. The drug is further administered after medical condition of myocardial infraction.

The mechanism of action of the drug is via ATIII. It inhibits the release of Factor Xa. The factor Xa is associated with blood coagulation mechanism and directly inhibits thrombin and thrombus formation.

Learn more about coagulation -

https://brainly.in/question/5567737

#SPJ4